Middle East & Africa DNA Plasmid Manufacturing Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type (GMP Grade and R&D grade), Application (Cell and Gene Therapy, DNA Vaccines, Immunotherapy, and Others), and End User (Pharmaceutical and Biotechnology Companies, CROs and CDMOs, and Others)
The Middle East & Africa DNA Plasmid Manufacturing Market is poised for significant growth, projected to reach approximately US$ 36.1 million by 2031, up from US$ 10.0 million in 2024. This growth trajectory indicates a robust compound annual growth rate (CAGR) of 20.4% from 2025 to 2031.
Executive Summary
The market is primarily segmented into key regions: Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The expansion of the biotechnology and pharmaceutical sectors, coupled with an increasing demand for genetic therapies, vaccine development, and genomic research, is driving this market forward. Notably, countries like Israel, Saudi Arabia, the UAE, and South Africa have made significant strides in enhancing their biotechnology infrastructure.
Israel stands out with its advanced research ecosystem and a strong presence of globally recognized biotech firms such as Teva Pharmaceuticals and Pluristem Therapeutics, which are heavily involved in the production of DNA plasmids for gene therapy and vaccine development. Saudi Arabia and the UAE are also making substantial investments in their biotechnology sectors as part of their Vision 2030 and Vision 2021 initiatives, respectively. Research hubs like the Dubai Science Park and King Abdulaziz City for Science and Technology (KACST) are pivotal in fostering advancements in DNA plasmid manufacturing and genomic research.
South Africa has emerged as a significant player in the plasmid DNA production landscape, particularly for gene therapy applications and vaccine manufacturing. Local companies such as BioVac and Zypharm are contributing to the growth of the biotechnology sector, driven by the increasing demand for local manufacturing capabilities to serve both regional and global markets.
Market Segmentation
The Middle East & Africa DNA Plasmid Manufacturing Market can be segmented by product type, application, and end user:
The rising prevalence of genetic diseases, orphan diseases, and various cancers has accelerated the development of gene therapy technologies, which rely heavily on plasmid DNA as a core component. Plasmid DNA serves as a non-viral vector to deliver therapeutic genes that can correct or replace defective genes. Compared to viral vectors, plasmids are considered safer, easier to produce, and more cost-effective, making them increasingly popular in gene therapy applications.
As gene therapies progress from preclinical stages to clinical trials and eventual commercial launch, the demand for high-purity, GMP-grade plasmid DNA has surged. For instance, in March 2023, Charles River Laboratories International, Inc. introduced its off-the-shelf pHelper (Helper Plasmid) offering, aimed at securing supply and streamlining adeno-associated virus (AAV)-based gene therapy programs from early discovery through to commercial manufacturing.
Moreover, partnerships between companies are growing to meet the stringent quality and regulatory requirements of gene therapy pipelines. A notable example is the 2022 partnership between Myrtelle and Forge Biologics, which focuses on viral vector and plasmid DNA cGMP manufacturing, highlighting the collaborative efforts to enhance the production capabilities for gene therapies.
Country Insights
In terms of country-specific insights, South Africa is currently leading the market share in 2024. The country boasts a well-established healthcare system and significant investments in research and development, positioning it as a regional leader in DNA plasmid manufacturing. The demand for DNA plasmids is driven by the rapid growth of biopharmaceutical industries and the expansion of clinical trials for genetic-based treatments. South Africa's diverse patient populations and favorable regulatory frameworks make it an attractive destination for international biotechnology firms. Local companies like BioVac and Zypharm are actively engaged in plasmid DNA production, benefiting from collaborations with global pharmaceutical companies and universities.
The increasing need for DNA plasmids in gene therapies and vaccine development is propelling market growth. South Africa's involvement in initiatives like the South African Vaccine Development Initiative (SAVDI) underscores the critical role of plasmid DNA in modern healthcare solutions. Furthermore, government support through the Department of Science and Innovation (DSI) fosters an innovation-driven environment, further enhancing the growth prospects of the DNA plasmid manufacturing market in the region.
Conclusion
The Middle East & Africa DNA Plasmid Manufacturing Market is on a promising growth path, driven by advancements in biotechnology, increasing demand for gene therapies, and supportive government initiatives. As the market evolves, it is expected to play a crucial role in the development of innovative therapeutic solutions.
Executive Summary
The market is primarily segmented into key regions: Saudi Arabia, South Africa, the UAE, and the Rest of Middle East & Africa. The expansion of the biotechnology and pharmaceutical sectors, coupled with an increasing demand for genetic therapies, vaccine development, and genomic research, is driving this market forward. Notably, countries like Israel, Saudi Arabia, the UAE, and South Africa have made significant strides in enhancing their biotechnology infrastructure.
Israel stands out with its advanced research ecosystem and a strong presence of globally recognized biotech firms such as Teva Pharmaceuticals and Pluristem Therapeutics, which are heavily involved in the production of DNA plasmids for gene therapy and vaccine development. Saudi Arabia and the UAE are also making substantial investments in their biotechnology sectors as part of their Vision 2030 and Vision 2021 initiatives, respectively. Research hubs like the Dubai Science Park and King Abdulaziz City for Science and Technology (KACST) are pivotal in fostering advancements in DNA plasmid manufacturing and genomic research.
South Africa has emerged as a significant player in the plasmid DNA production landscape, particularly for gene therapy applications and vaccine manufacturing. Local companies such as BioVac and Zypharm are contributing to the growth of the biotechnology sector, driven by the increasing demand for local manufacturing capabilities to serve both regional and global markets.
Market Segmentation
The Middle East & Africa DNA Plasmid Manufacturing Market can be segmented by product type, application, and end user:
- By Product Type: The market is divided into GMP Grade and R&D Grade, with GMP Grade holding the largest market share in 2024.
- By Application: The applications include Cell and Gene Therapy, DNA Vaccines, Immunotherapy, and others, with Cell and Gene Therapy leading the market in 2024.
- By End User: The end users are categorized into Pharmaceutical and Biotechnology Companies, CROs and CDMOs, and others, where Pharmaceutical and Biotechnology Companies dominate the market share in 2024.
The rising prevalence of genetic diseases, orphan diseases, and various cancers has accelerated the development of gene therapy technologies, which rely heavily on plasmid DNA as a core component. Plasmid DNA serves as a non-viral vector to deliver therapeutic genes that can correct or replace defective genes. Compared to viral vectors, plasmids are considered safer, easier to produce, and more cost-effective, making them increasingly popular in gene therapy applications.
As gene therapies progress from preclinical stages to clinical trials and eventual commercial launch, the demand for high-purity, GMP-grade plasmid DNA has surged. For instance, in March 2023, Charles River Laboratories International, Inc. introduced its off-the-shelf pHelper (Helper Plasmid) offering, aimed at securing supply and streamlining adeno-associated virus (AAV)-based gene therapy programs from early discovery through to commercial manufacturing.
Moreover, partnerships between companies are growing to meet the stringent quality and regulatory requirements of gene therapy pipelines. A notable example is the 2022 partnership between Myrtelle and Forge Biologics, which focuses on viral vector and plasmid DNA cGMP manufacturing, highlighting the collaborative efforts to enhance the production capabilities for gene therapies.
Country Insights
In terms of country-specific insights, South Africa is currently leading the market share in 2024. The country boasts a well-established healthcare system and significant investments in research and development, positioning it as a regional leader in DNA plasmid manufacturing. The demand for DNA plasmids is driven by the rapid growth of biopharmaceutical industries and the expansion of clinical trials for genetic-based treatments. South Africa's diverse patient populations and favorable regulatory frameworks make it an attractive destination for international biotechnology firms. Local companies like BioVac and Zypharm are actively engaged in plasmid DNA production, benefiting from collaborations with global pharmaceutical companies and universities.
The increasing need for DNA plasmids in gene therapies and vaccine development is propelling market growth. South Africa's involvement in initiatives like the South African Vaccine Development Initiative (SAVDI) underscores the critical role of plasmid DNA in modern healthcare solutions. Furthermore, government support through the Department of Science and Innovation (DSI) fosters an innovation-driven environment, further enhancing the growth prospects of the DNA plasmid manufacturing market in the region.
Conclusion
The Middle East & Africa DNA Plasmid Manufacturing Market is on a promising growth path, driven by advancements in biotechnology, increasing demand for gene therapies, and supportive government initiatives. As the market evolves, it is expected to play a crucial role in the development of innovative therapeutic solutions.
1. INTRODUCTION
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. MIDDLE EAST & AFRICA DNA PLASMID MANUFACTURING MARKET - KEY MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. DNA PLASMID MANUFACTURING MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
5.1 Middle East & Africa DNA Plasmid Manufacturing Market Revenue (US$ Million), 2024 - 2031
5.2 Middle East & Africa DNA Plasmid Manufacturing Market Forecast and Analysis
6. MIDDLE EAST & AFRICA DNA PLASMID MANUFACTURING MARKET REVENUE ANALYSIS - BY PRODUCT TYPE
6.1 GMP Grade
6.1.1 Overview
6.1.2 GMP Grade: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 R&D grade
6.2.1 Overview
6.2.2 R&D grade: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. MIDDLE EAST & AFRICA DNA PLASMID MANUFACTURING MARKET REVENUE ANALYSIS - BY APPLICATION
7.1 Cell and Gene Therapy
7.1.1 Overview
7.1.2 Cell and Gene Therapy: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 DNA Vaccines
7.2.1 Overview
7.2.2 DNA Vaccines: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Immunotherapy
7.3.1 Overview
7.3.2 Immunotherapy: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA DNA PLASMID MANUFACTURING MARKET REVENUE ANALYSIS - BY END USER
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Overview
8.1.2 Pharmaceutical and Biotechnology Companies: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 CROs and CDMOs
8.2.1 Overview
8.2.2 CROs and CDMOs: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA DNA PLASMID MANUFACTURING MARKET - COUNTRY ANALYSIS
9.1 Middle East & Africa
9.1.1 Middle East & Africa DNA Plasmid Manufacturing Market Revenue and Forecast and Analysis - by Country
9.1.1.1 Middle East & Africa DNA Plasmid Manufacturing Market Revenue and Forecast and Analysis - by Country
9.1.2.2 Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.1.2.2.1 Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Product Type
9.1.2.2.2 Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Application
9.1.2.2.3 Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market Share - by End User
9.2.3.3 South Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2.3.3.1 South Africa: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Product Type
9.2.3.3.2 South Africa: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Application
9.2.3.3.3 South Africa: Middle East & Africa DNA Plasmid Manufacturing Market Share - by End User
9.3.4.4 United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3.4.4.1 United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Product Type
9.3.4.4.2 United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Application
9.3.4.4.3 United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market Share - by End User
9.4.5.5 Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Product Type
9.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Application
9.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market Share - by End User
10 COMPETITIVE LANDSCAPE
10.1 Heat Map Analysis by Key Players
10.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
11.1 Overview
11.2 New Product Development
11.3 Merger and Acquisition
11.4 Other Strategic Developments
13 COMPANY PROFILES
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Catalent Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 WuXi Biologics Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GenScript Biotech Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Takara Bio Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 AGC Biologics AS
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Thermo Fisher Scientific Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 SK pharmteco Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Creative Biogene
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
1.1 Report Guidance
1.2 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
3. RESEARCH METHODOLOGY
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. MIDDLE EAST & AFRICA DNA PLASMID MANUFACTURING MARKET - KEY MARKET DYNAMICS
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. DNA PLASMID MANUFACTURING MARKET - MIDDLE EAST & AFRICA MARKET ANALYSIS
5.1 Middle East & Africa DNA Plasmid Manufacturing Market Revenue (US$ Million), 2024 - 2031
5.2 Middle East & Africa DNA Plasmid Manufacturing Market Forecast and Analysis
6. MIDDLE EAST & AFRICA DNA PLASMID MANUFACTURING MARKET REVENUE ANALYSIS - BY PRODUCT TYPE
6.1 GMP Grade
6.1.1 Overview
6.1.2 GMP Grade: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 R&D grade
6.2.1 Overview
6.2.2 R&D grade: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. MIDDLE EAST & AFRICA DNA PLASMID MANUFACTURING MARKET REVENUE ANALYSIS - BY APPLICATION
7.1 Cell and Gene Therapy
7.1.1 Overview
7.1.2 Cell and Gene Therapy: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 DNA Vaccines
7.2.1 Overview
7.2.2 DNA Vaccines: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Immunotherapy
7.3.1 Overview
7.3.2 Immunotherapy: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. MIDDLE EAST & AFRICA DNA PLASMID MANUFACTURING MARKET REVENUE ANALYSIS - BY END USER
8.1 Pharmaceutical and Biotechnology Companies
8.1.1 Overview
8.1.2 Pharmaceutical and Biotechnology Companies: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 CROs and CDMOs
8.2.1 Overview
8.2.2 CROs and CDMOs: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Others
8.3.1 Overview
8.3.2 Others: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. MIDDLE EAST & AFRICA DNA PLASMID MANUFACTURING MARKET - COUNTRY ANALYSIS
9.1 Middle East & Africa
9.1.1 Middle East & Africa DNA Plasmid Manufacturing Market Revenue and Forecast and Analysis - by Country
9.1.1.1 Middle East & Africa DNA Plasmid Manufacturing Market Revenue and Forecast and Analysis - by Country
9.1.2.2 Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.1.2.2.1 Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Product Type
9.1.2.2.2 Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Application
9.1.2.2.3 Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market Share - by End User
9.2.3.3 South Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2.3.3.1 South Africa: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Product Type
9.2.3.3.2 South Africa: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Application
9.2.3.3.3 South Africa: Middle East & Africa DNA Plasmid Manufacturing Market Share - by End User
9.3.4.4 United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3.4.4.1 United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Product Type
9.3.4.4.2 United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Application
9.3.4.4.3 United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market Share - by End User
9.4.5.5 Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Product Type
9.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market Share - by Application
9.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market Share - by End User
10 COMPETITIVE LANDSCAPE
10.1 Heat Map Analysis by Key Players
10.2 Company Positioning & Concentration
12 INDUSTRY LANDSCAPE
11.1 Overview
11.2 New Product Development
11.3 Merger and Acquisition
11.4 Other Strategic Developments
13 COMPANY PROFILES
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Catalent Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 WuXi Biologics Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GenScript Biotech Corporation
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Takara Bio Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 AGC Biologics AS
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Thermo Fisher Scientific Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 SK pharmteco Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Creative Biogene
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
LIST OF TABLES
Table 1. Middle East & Africa DNA Plasmid Manufacturing Market Segmentation
Table 3. Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 5. Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 9. Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. South Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 12. South Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 13. South Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 15. United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 18. Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Heat Map Analysis by Key Players
Table 1. Middle East & Africa DNA Plasmid Manufacturing Market Segmentation
Table 3. Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 5. Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 6. Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 7. Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 8. Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 9. Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 11. South Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 12. South Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 13. South Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 14. United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 15. United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 16. United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 17. Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
Table 18. Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 20. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Middle East & Africa DNA Plasmid Manufacturing Market Segmentation - Country
Figure 4. Middle East & Africa DNA Plasmid Manufacturing Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa DNA Plasmid Manufacturing Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa DNA Plasmid Manufacturing Market Share (%) - by Product Type, 2024 and 2031
Figure 8. GMP Grade: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. R&D grade: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Middle East & Africa DNA Plasmid Manufacturing Market Share (%) - by Application, 2024 and 2031
Figure 11. Cell and Gene Therapy: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. DNA Vaccines: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Immunotherapy: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Others: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Middle East & Africa DNA Plasmid Manufacturing Market Share (%) - by End User, 2024 and 2031
Figure 16. Pharmaceutical and Biotechnology Companies: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. CROs and CDMOs: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Middle East & Africa DNA Plasmid Manufacturing Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 20. Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. South Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Company Positioning & Concentration
Figure 1. Middle East & Africa DNA Plasmid Manufacturing Market Segmentation - Country
Figure 4. Middle East & Africa DNA Plasmid Manufacturing Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa DNA Plasmid Manufacturing Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa DNA Plasmid Manufacturing Market Share (%) - by Product Type, 2024 and 2031
Figure 8. GMP Grade: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. R&D grade: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Middle East & Africa DNA Plasmid Manufacturing Market Share (%) - by Application, 2024 and 2031
Figure 11. Cell and Gene Therapy: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. DNA Vaccines: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Immunotherapy: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Others: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Middle East & Africa DNA Plasmid Manufacturing Market Share (%) - by End User, 2024 and 2031
Figure 16. Pharmaceutical and Biotechnology Companies: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. CROs and CDMOs: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Middle East & Africa DNA Plasmid Manufacturing Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 20. Saudi Arabia: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. South Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. United Arab Emirates: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. Rest of Middle East & Africa: Middle East & Africa DNA Plasmid Manufacturing Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. Company Positioning & Concentration
